Another Infliximab Biosimilar On Horizon In India?

 
• By Anju Ghangurde
  
Eclipse
BIOCAD'S INFLIXIMAB HAS RECEIVED A KEY APPROVAL IN INDIA BUT LAUNCH PLANS ARE HAZY • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia